Diasorin - 6 Month Bridge

Background
The Department of Veterans Affairs, Network Contracting Office (NCO) 22, is issuing a Notice of Intent to execute a firm fixed price, Sole Source Award for immunoassay reagent services. The intended contractor is DiaSorin INC, a large business vendor located in Stillwater, MN.

The VA requires these services for the DiaSorin LIAISON XL instrument system due to the proprietary nature of the products, which are exclusively supported by DiaSorin.

Work Details
The contract involves the acquisition of all-inclusive Chemiluminescence Immunoassay Reagent Services for various VA Healthcare systems. The specific locations include: VA Long Beach Healthcare System, VA Loma Linda Healthcare System, VA San Diego Healthcare System, VA Southern Arizona Healthcare System, VA Greater Los Angeles Healthcare System West LA Campus, and Phoenix VA Healthcare System.

The contractor must have direct OEM experience with the Medtronic Endoflip 300 Impedance Planimetry System and Supplies. Responsibilities include providing all necessary test parts, equipment, tools, and materials for performance of the contract while complying with all VA security and safety requirements. The contractor must also ensure that all work is performed by qualified personnel following the original manufacturer’s instructions.

Place of Performance
Services will be performed at multiple locations including Long Beach, Loma Linda, San Diego, Tucson, Los Angeles, and Phoenix.

Bidder Requirements
The contractor must demonstrate OEM privileges and have access to necessary software and technical support resources. Compliance with VA security and privacy requirements is mandatory. Additionally, bidders must provide information regarding their capabilities to meet the DRAFT SOW requirements and confirm their status as an authorized distributor or manufacturer.

Incumbent Analysis (see Incumbents section for more detail)
This opportunity appears to have a confirmed incumbent, with DiaSorin awarded contract 36C26225P0816 for immunoassay reagents valued at $2,273,034 (03/20/25–09/19/26). The prior work is described as immunoassay reagents and aligns with the current need for all-inclusive Chemiluminescence Immunoassay Reagent Services for the DiaSorin LIAISON XL instrument system, suggesting continuity of OEM reagent supply and support. Additionally, closely related DiaSorin IDVs (e.g., consumables and reagents for LIAISON XL instruments) indicate ongoing provision of proprietary reagents/consumables and related services at VA medical centers.